Etiology and Management of Bleeding during ECMO in a COVID-19 Patient
- PMID: 33487607
- PMCID: PMC8147565
- DOI: 10.5551/jat.61747
Etiology and Management of Bleeding during ECMO in a COVID-19 Patient
Keywords: Acquired von Willebrand syndrome; Bleeding; Disseminated intravascular coagulation; Endotheliitis; Extracorporeal membrane oxygenation.
Conflict of interest statement
None of the authors have any conflicts of interest to report.
Comment in
-
Response to "Etiology and Management of Bleeding during ECMO in a COVID-19 Patient".J Atheroscler Thromb. 2021 Apr 1;28(4):404-405. doi: 10.5551/jat.61747-R. Epub 2021 Jan 23. J Atheroscler Thromb. 2021. PMID: 33487608 Free PMC article. No abstract available.
Comment on
-
Management of a COVID-19 Patient during ECMO: Paying Attention to Acquired von Willebrand Syndrome.J Atheroscler Thromb. 2021 Apr 1;28(4):396-401. doi: 10.5551/jat.58362. Epub 2020 Oct 28. J Atheroscler Thromb. 2021. PMID: 33116032 Free PMC article.
References
-
- Yamada S, Okumura H, Morishita E, Asakura H. Complete hemostasis achieved by factor XIII concentrate administration in a patient with bleeding after teeth extraction as a complication of aplastic anemia and chronic disseminated intravascular coagulation. Blood Coagul Fibrinolysis, 2020; 31: 274-278 - PubMed
-
- Hoshino K, Muranishi K, Kawano Y, Hatomoto H, Yamasaki S, Nakamura Y, Ishikura H. Soluble fibrin is a useful marker for predicting extracorporeal membrane oxygenation circuit exchange because of circuit clots. J Artif Organs, 2018; 21: 196-200 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
